Narrowing mortality gap between men and women over two decades: a registry-based study in Ontario, Canada
Rosella LC, Calzavara A, Frank JW, Fitzpatrick T, Donnelly PD, Henry D. BMJ Open. 2016: 6(11):e012564. Epub 2016 Nov 14.
Publications
Effectiveness of pertussis vaccination and duration of immunity
Schwartz KL, Kwong JC, Deeks SL, Campitelli MA, Jamieson FB, Marchand-Austin A, Stukel TA, Rosella L, Daneman N, Bolotin S, Drews SJ, Rilkoff H, Crowcroft NS. CMAJ. 2016; 188(16):E399-406. Epub 2016 Sep 26.
Measuring burden of unhealthy behaviours using a multivariable predictive approach: life expectancy lost in Canada attributable to smoking, alcohol, physical inactivity, and diet
Manuel DG, Perez R, Sanmartin C, Taljaard M, Hennessy D, Wilson K, Tanuseputro P, Manson H, Bennett C, Tuna M, Fisher S, Rosella LC. PLoS Med. 2016; 13(8):e1002082.
Early impact of Ontario’s human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): a population-based assessment
Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL. Vaccine. 2016; 34(39):4678-83. Epub 2016 Aug 12.
Survival and surgical interventions for children with trisomy 13 and 18
Nelson KE, Rosella LC, Mahant S, Guttmann A. JAMA. 2016; 316(4):420-8. Epub 2016 Jul 26.
The economic burden of hospital-acquired Clostridium difficile infection: a population-based matched cohort study
Nanwa N, Kwong JC, Krahn M, Daneman N, Lu H, Austin PC, Govindarajan A, Rosella LC, Cadarette SM, Sander B. Infect Control Hosp Epidemiol. 2016; 37(9):1068-78. Epub 2016 Jun 20.
Association of neighborhood walkability with change in overweight, obesity, and diabetes
Creatore MI, Glazier RH, Moineddin R, Fazli GS, Johns A, Gozdyra P, Matheson FI, Kaufman-Shriqui V, Rosella LC, Manuel DG, Booth GL. JAMA. 2016; 315(20):2211-20. Epub 2016 May 24.
Population-level impact of Ontario’s infant rotavirus immunization program: evidence of direct and indirect effects
Wilson SE, Rosella LC, Wang J, Le Saux N, Crowcroft NS, Harris T, Bolotin S, Deeks SL. PLoS One. 2016; 11(5):e0154340. Epub 2016 May 11.
Risk of bias in systematic reviews of non-randomized studies of adverse cardiovascular effects of thiazolidinediones and cyclooxygenase-2 inhibitors: application of a new Cochrane risk of bias tool
Bilandzic A, Fitzpatrick T, Rosella L, Henry D. PLoS Med. 2016; 13(4):e1001987.
Health service utilisation for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine programme introduction: a retrospective longitudinal population-based study
Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL. BMJ Open. 2016; 6(3):e009914.